0 items USD 0.00Search
Your search for "qyresearch united states renal cell carcinoma drug industry 2016 market research report" gave back 1504912 results.
Renal cell carcinoma is the most common type of kidney cancer in adults. It accounts for approximately 3% of adult malignancies and 90-95% of...
Catalog:
iGATE
May 2016
Price: USD 1,190.00
Summary The global Kidney Cancer Drugs market will reach xxx Million USD in 2021 with CAGR xx% 2021-2026. The objective of report is to define,...
Catalog:
HYR
January 2022
Price: USD 2,540.00
Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Pipeline Review, H2 2018 Summary Interleukin...
Catalog:
Global Markets Direct
July 2018
Price: USD 3,500.00
Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Pipeline Review, H1 2018 Summary According...
Catalog:
Global Markets Direct
January 2018
Price: USD 3,500.00
Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Pipeline Review, H1 2019 Summary Interleukin...
Catalog:
Global Markets Direct
April 2019
Price: USD 3,500.00
RAC Alpha Serine/Threonine Protein Kinase (Protein kinase B or Protein kinase B Alpha or Proto Oncogene c Akt or RAC PK Alpha or AKT1 or EC 2.7.11.1...
Catalog:
Global Markets Direct
May 2018
Price: USD 3,500.00
The global Kidney Cancer and Renal Cell Carcinoma (RCC) Drugs market size was valued at US$ 4996.3 million in 2023. With growing demand in downstream...
Catalog:
LPI
March 2024
Price: USD 3,660.00
Kidney cancer/ renal cell carcinoma (RCC) is among ten most commonly observed cancer these days. It is sixth common cancer observed in men and it is...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Renal cell carcinoma (RCC) is a kidney cancer that originates in the lining of the proximal convoluted tubule, a part of the very small tubes in the...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Kidney cancer/ renal cell carcinoma (RCC) is among ten most commonly observed cancer these days. It is sixth common cancer observed in men and it is...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Kidney cancer/ renal cell carcinoma (RCC) is among ten most commonly observed cancer these days. It is sixth common cancer observed in men and it is...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Renal cell carcinoma (RCC) is a kidney cancer that originates in the lining of the proximal convoluted tubule, a part of the very small tubes in the...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Tumor Necrosis Factor Receptor Superfamily Member 18 (Glucocorticoid Induced Tumor Necrosis Factor Receptor or Activation Inducible TNFR Family...
Catalog:
Global Markets Direct
March 2019
Price: USD 3,500.00
Macrophage Stimulating Protein Receptor (CDw136 or Protein Tyrosine Kinase 8 or p185 Ron or CD136 or MST1R or EC 2.7.10.1) - Pipeline Review, H1 2018...
Catalog:
Global Markets Direct
January 2018
Price: USD 3,500.00
Tumor Necrosis Factor Receptor Superfamily Member 18 - Pipeline Review, H2 2019 Summary Tumor Necrosis Factor Receptor Superfamily Member 18 (...
Catalog:
Global Markets Direct
August 2019
Price: USD 3,500.00
Filter By Report Date
Filter By Industry
Filter By Country
- (-) Remove Global filter Global
- Latin America (4) Apply Latin America filter
- Middle East (3) Apply Middle East filter
- Africa (2) Apply Africa filter
- America (1) Apply America filter
- Americas (1) Apply Americas filter
- Asia (1) Apply Asia filter
- BRIC (1) Apply BRIC filter
- Caribbean (1) Apply Caribbean filter
- Oceania (1) Apply Oceania filter
